Diabetes is a rising global epidemic that will soon affect 10% of the world’s population. My research is focused around developing a new therapeutic molecule to cure diabetes, in contrast to current therapeutics, which only manage symptoms. We are developing molecules that force the beta cells of the pancreas, which are lost during diabetes, to regenerate and thus eliminate the effects of the disease. My main challenge is to design these molecules so that they will cause only the beta cells to regenerate without affecting any other tissues. To tackle this problem, I am employing a number of drug-targeting strategies and testing their efficacy both in biochemical and living systems. This is an exciting project that allows me to use a multitude of approaches from chemistry and biology, to have a significant impact on healing diabetic people.